Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lockwood

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Biopharmaceutics & Drug Disposition|May 1, 1987
Pharmacokinetics of flurbiprofen in man. I. Area/dose relationshipsG J Szpunar, K S Albert, G G Bole, et al.
Peerj|June 15, 2022
A European giant: a large spinosaurid (Dinosauria: Theropoda) from the Vectis Formation (Wealden Group, Early Cretaceous), UKChris T Barker, Jeremy A F Lockwood, Darren Naish, et al.
European Journal of Drug Metabolism and Pharmacokinetics|March 15, 2000
Characterization of the highly variable bioavailability of tiludronate in normal volunteers using population pharmacokinetic methodologiesG A Maier, G F Lockwood, J A Oppermann, et al.
Journal of Cardiovascular Pharmacology|June 21, 2006
Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicityR Preston Mason, Mary F Walter, Hyesun P McNulty, et al.
Chemistry and Physics of Lipids|May 29, 2007
Hydrophilic carotenoids: surface properties and aggregation of an astaxanthin-lysine conjugate, a rigid, long-chain, highly unsaturated and highly water-soluble tetracationic bolaamphiphileStine Nalum Naess, Hans-Richard Sliwka, Vassilia Partali, et al.
Clinical Pharmacology and Therapeutics|July 1, 1983
Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationshipsG F Lockwood, K S Albert, W R Gillespie, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1973
Humoral and cell-mediated immunity in transfused uraemicsJ B Dossetor, T Kovithavongs, V S Lao, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 7, 2007
Electron- and energy-transfer properties of hydrophilic carotenoidsHans-Richard Sliwka, Thor-Bernt Melø, Bente Jeanette Foss, et al.
Journal of Toxicology and Environmental Health. Part A|July 27, 2001
Urinary cadmium elimination as a biomarker of exposure for evaluating a cadmium dietary exposure--biokinetics modelH Choudhury, T Harvey, W C Thayer, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1995
Dose regimen adjustment for milrinone in congestive heart failure patients with moderate and severe renal failureS G Woolfrey, J Hegbrant, H Thysell, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Biopharmaceutics & Drug Disposition|May 1, 1987
Pharmacokinetics of flurbiprofen in man. I. Area/dose relationshipsG J Szpunar, K S Albert, G G Bole, et al.
Peerj|June 15, 2022
A European giant: a large spinosaurid (Dinosauria: Theropoda) from the Vectis Formation (Wealden Group, Early Cretaceous), UKChris T Barker, Jeremy A F Lockwood, Darren Naish, et al.
European Journal of Drug Metabolism and Pharmacokinetics|March 15, 2000
Characterization of the highly variable bioavailability of tiludronate in normal volunteers using population pharmacokinetic methodologiesG A Maier, G F Lockwood, J A Oppermann, et al.
Journal of Cardiovascular Pharmacology|June 21, 2006
Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicityR Preston Mason, Mary F Walter, Hyesun P McNulty, et al.
Chemistry and Physics of Lipids|May 29, 2007
Hydrophilic carotenoids: surface properties and aggregation of an astaxanthin-lysine conjugate, a rigid, long-chain, highly unsaturated and highly water-soluble tetracationic bolaamphiphileStine Nalum Naess, Hans-Richard Sliwka, Vassilia Partali, et al.
Clinical Pharmacology and Therapeutics|July 1, 1983
Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationshipsG F Lockwood, K S Albert, W R Gillespie, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1973
Humoral and cell-mediated immunity in transfused uraemicsJ B Dossetor, T Kovithavongs, V S Lao, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 7, 2007
Electron- and energy-transfer properties of hydrophilic carotenoidsHans-Richard Sliwka, Thor-Bernt Melø, Bente Jeanette Foss, et al.
Journal of Toxicology and Environmental Health. Part A|July 27, 2001
Urinary cadmium elimination as a biomarker of exposure for evaluating a cadmium dietary exposure--biokinetics modelH Choudhury, T Harvey, W C Thayer, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1995
Dose regimen adjustment for milrinone in congestive heart failure patients with moderate and severe renal failureS G Woolfrey, J Hegbrant, H Thysell, et al.
Pageof 8